Biltmore Wealth Management, LLC Amgen Inc Transaction History

Biltmore Wealth Management, LLC

  • $242 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 08, 2019
SELL
$180.87 - $203.88 $588,189 - $663,017
-3,252 Closed
0 $0
Q4 2018

Jan 14, 2019
SELL
$178.4 - $208.25 $47,454 - $55,394
-266 Reduced 7.56%
3,252 $633,000
Q3 2018

Oct 10, 2018
BUY
$185.29 - $208.89 $651,850 - $734,875
3,518 New
3,518 $729,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Biltmore Wealth Management, LLC Portfolio

Follow Biltmore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email